OCULAR THERAPEUTIX, INC (33)
Browse by Contract Category
Contracts
-
Consulting Agreement by and between the Registrant and Dr. Michael Goldstein, dated as of June 7, 2022
(Filed With SEC on August 8, 2022)
-
Amendment No. 1 to License Agreement, by and between the Registrant and AffaMed Therapeutics (HK) Limited, dated as of October 28, 2021
(Filed With SEC on February 28, 2022)
-
Description of Securities Registered under Section 12 of the Exchange Act
(Filed With SEC on February 28, 2022)
-
Fourth Amended and Restated Credit and Security Agreement dated June 4, 2021 by and among MidCap Financial Trust, as administrative agent, Ocular Therapeutix, Inc., and the...
(Filed With SEC on June 4, 2021)
-
Amendment to Collaboration, Option and License Agreement, by and between the Company and Regeneron, dated May 8, 2020
(Filed With SEC on May 14, 2020)
-
Sublease, dated as of April 4, 2019, by and among Ocular Therapeutix, Inc. and Holcim (US) Inc
(Filed With SEC on May 10, 2019)
-
2021 Stock Incentive Plan, as amended
(Filed With SEC on August 8, 2022)
-
Form of Restricted Stock Unit Agreement under 2021 Stock Incentive Plan
(Filed With SEC on February 28, 2022)
-
Form of Option Grant Agreement under 2021 Stock Incentive Plan
(Filed With SEC on February 28, 2022)
-
Open Market Sale AgreementSM, dated as of August 9, 2021, by and between Ocular Therapeutix, Inc. and Jefferies LLC
(Filed With SEC on August 9, 2021)
-
Supplement to License Agreement, by and between the Registrant and AffaMed Therapeutics Limited, dated as of January 18, 2021
(Filed With SEC on March 11, 2021)
-
Employment Agreement, by and between the Registrant and Philip Strassburger, dated August 28, 2020
(Filed With SEC on March 11, 2021)
-
Amendment to 2019 Inducement Stock Incentive Plan
(Filed With SEC on March 11, 2021)
-
Underwriting Agreement, dated December 15, 2020, by and among Ocular Therapeutix, Inc. and Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters...
(Filed With SEC on December 18, 2020)
-
License Agreement, by and between the Registrant and AffaMed Therapeutics Limited, dated October 29, 2020
(Filed With SEC on November 5, 2020)
-
Underwriting Agreement, dated October 13, 2020, by and among Ocular Therapeutix, Inc. and Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters...
(Filed With SEC on October 16, 2020)
-
Underwriting Agreement, dated May 19, 2020, by and among Ocular Therapeutix, Inc. and Jefferies LLC and Piper Sandler & Co., as representatives of the several underwriters named...
(Filed With SEC on May 22, 2020)
-
Employment Agreement, by and between the Registrant and Patricia Kitchen, dated as April 21, 2019
(Filed With SEC on May 8, 2020)
-
Separation and Release of Claims Agreement by and between the Registrant and Daniel Bollag, dated December 2, 2019
(Filed With SEC on March 12, 2020)
-
Description of Securities Registered under Section 12 of the Exchange Act
(Filed With SEC on March 12, 2020)
-
Form of Inducement Nonstatutory Stock Option Agreement
(Filed With SEC on November 12, 2019)
-
2019 Inducement Stock Incentive Plan
(Filed With SEC on November 12, 2019)
-
Consulting Agreement by and between Ocular Therapeutix, Inc. and Kevin Hanley, dated as of August 2, 2019
(Filed With SEC on August 7, 2019)
-
Transition, Separation and Release of Claims Agreement by and between Ocular Therapeutix, Inc. and Kevin Hanley, dated as of August 2, 2019
(Filed With SEC on August 7, 2019)
-
Second Amendment to Third Amended and Restated Credit and Security Agreement, by and among Ocular Therapeutix, Inc., MidCap Financial Trust as administrative agent, and the...
(Filed With SEC on August 7, 2019)
-
Consulting Agreement by and between Ocular Therapeutix, Inc. and Dr. Amarpreet S. Sawhney, dated as of May 29, 2019
(Filed With SEC on May 30, 2019)
-
Transition, Separation and Release of Claims Agreement by and between Ocular Therapeutix, Inc. and Dr. Amarpreet S. Sawhney, dated as of May 29, 2019
(Filed With SEC on May 30, 2019)
-
Open Market Sales AgreementSM, dated as of April 5, 2019, by and between Ocular Therapeutix, Inc. and Jefferies LLC
(Filed With SEC on April 5, 2019)
-
Registration Rights Agreement, dated as of March 1, 2019, by and among the Registrant and the Purchasers identified therein
(Filed With SEC on March 7, 2019)
-
Note Purchase Agreement (including Form of Senior Subordinated Convertible Note), dated as of February 21, 2019, by and among Ocular Therapeutix, Inc. and the Purchasers listed...
(Filed With SEC on February 22, 2019)
-
Subordination Agreement, dated as of February 21, 2019, by and among Ocular Therapeutix, Inc., MidCap Financial Trust, as administrative agent, and the Lenders listed therein
(Filed With SEC on February 22, 2019)
-
First Amendment to Third Amended and Restated Credit and Security Agreement, dated as of February 21, 2019, by and among Ocular Therapeutix, Inc., MidCap Financial Trust, as...
(Filed With SEC on February 22, 2019)
-
Form of Registration Rights Agreement by and among Ocular Therapeutix, Inc. and the Purchasers listed therein
(Filed With SEC on February 22, 2019)